Northwest Biotherapeutics, Bristol-Myers Squibb: Success For The Yervoy-Opdivo Combination
September 07, 2017 at 11:29 AM EDT
The stoppage at an interim analysis of Bristol-Myers Squibb’s’ Checkmate-214 trial provides meaningful information into assessing the potential for success of Northwest Biotherapeutics.
